On December 14, 2011, the Food and Drug Administration classified St. Jude Medical’s Riata defibrillator lead as a Class I recall, because of the “potential risk of serious injury or patient death if affected devices malfunction.”
On December 14, 2011, the Food and Drug Administration classified St. Jude Medical’s Riata defibrillator lead as a Class I recall, because of the “potential risk of serious injury or patient death if affected devices malfunction.”
Merkezi Klinika Hospital is located in the center of Baku, the capital of the Azerbaijan Republic. It is equipped with the latest technology and offers a full range of state-of-the-art diagnostic and therapeutic cardiovascular services.
Merkezi Klinika Hospital is located in the center of Baku, the capital of the Azerbaijan Republic. It is equipped with the latest technology and offers a full range of state-of-the-art diagnostic and therapeutic cardiovascular services.
This case illustrates a realistic dilemma when medical therapy has no additional benefit. Both VAD and transplant therapy have been shown to be helpful in certain patient populations, but it may not be applicable in all heart failure...
This case illustrates a realistic dilemma when medical therapy has no additional benefit. Both VAD and transplant therapy have been shown to be helpful in certain patient populations, but it may not be applicable in all heart failure...
The ability to use MR scans is important and will become even more important in the future. Until recently, patients with an ICD had been excluded from undergoing MR scans despite that these scans are critical for the diagnosis and therapy of...
The ability to use MR scans is important and will become even more important in the future. Until recently, patients with an ICD had been excluded from undergoing MR scans despite that these scans are critical for the diagnosis and therapy of...
Recently, dabigatran was approved for stroke prevention in the AF population, followed closely by rivaroxaban. Apixaban is also currently undergoing FDA review. The following is a summary of these new warfarin rivals.
Recently, dabigatran was approved for stroke prevention in the AF population, followed closely by rivaroxaban. Apixaban is also currently undergoing FDA review. The following is a summary of these new warfarin rivals.
The Society of Chest Pain Centers recently selected Genesis HealthCare System as one of 5 hospitals in the nation to participate in beta site testing for the forthcoming Atrial Fibrillation Certification.
The Society of Chest Pain Centers recently selected Genesis HealthCare System as one of 5 hospitals in the nation to participate in beta site testing for the forthcoming Atrial Fibrillation Certification.
EPLD speaks with Jagmeet P. Singh, MD, DPhil, Associate Professor of Medicine, Harvard Medical School, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center.
EPLD speaks with Jagmeet P. Singh, MD, DPhil, Associate Professor of Medicine, Harvard Medical School, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center.